Snoop Dogg Appeals for Privacy as He Quits Cannabis

News by 2FIRSTS.ai
Nov.17.2023
Snoop Dogg Appeals for Privacy as He Quits Cannabis
Famous rapper Snoop Dogg, also known as Calvin Cordozar Broadus Jr., announced he will give up marijuana, urging fans to respect his privacy.

According to a report from Lifeboxset, renowned American rapper Snoop Dogg, whose real name is Calvin Cordozar Broadus Jr., recently announced his decision to quit using marijuana and kindly requested his fans to respect his current privacy.

 

The rapper shared a message on his official social media platform, stating, "After profound introspection and conversations with my family, I have made the decision to quit smoking. I kindly request you to respect my privacy at this time.

 

No further details were provided apart from that.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts to Cease Sale of Flavored E-Cigarettes in California as Part of Settlement with NJOY: Court to Issue Permanent Injunction.
Heaven Gifts agrees to stop selling flavored disposable e-cigarettes in California as part of settlement with NJOY.
Oct.13 by 2FIRSTS.ai
RELX Launches Guide Dog Partner Program in China, Delivers First 10 Trained Dogs
RELX Launches Guide Dog Partner Program in China, Delivers First 10 Trained Dogs
RLX Technology has launched a RMB 4 million guide dog program in China, delivering the first 10 trained dogs as its RELX brand expands social responsibility efforts amid a nationwide shortage.
Nov.14
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s draft reform of its tobacco law has reached a critical stage. 2Firsts recently confirmed with Spanish government sources that the bill has completed the EU’s internal market review process and was approved by the Council of Ministers in early September. The decision means that, despite objections from the European Commission and several member states, Spain maintained its original provisions and has now moved the draft into parliamentary debate.
Sep.30
EU Plans Revised Tobacco Tax Directive: First Unified Rates for Heated Tobacco, E-Liquids, and Nicotine Pouches
EU Plans Revised Tobacco Tax Directive: First Unified Rates for Heated Tobacco, E-Liquids, and Nicotine Pouches
The European Commission’s proposed revision to the Tobacco Tax Directive (TTD) would take effect from 2028, raising minimum excise levels, introducing—For the first time—coordinated tax rates for heated tobacco, e-liquids, and nicotine pouches, and bringing raw tobacco under the excise control system. The plan also creates a “TEDOR” mechanism to assess a uniform 15% of tobacco excise as an EU own resource, projected to add about €11 billion annually to the EU budget.
Sep.28
Co-op Faces Backlash Over Vape Promotion Strategy Post-Cyberattack
Co-op Faces Backlash Over Vape Promotion Strategy Post-Cyberattack
The Guardian reports that UK retailer Co-op is ramping up vape promotions to recover sales lost after an April cyberattack. Internal documents cite a £1M weekly sales gap and 100,000 fewer transactions. Staff say the move contradicts Co-op’s “ethical retail” image, as the government prepares to ban vape ads under the Tobacco and Vapes Bill.
Oct.28 by 2FIRSTS.ai